CSL Ltd Annual Report 2020

Marie McDonald BSc (Hons), LLB (Hons) Age 63 Independent Non-executive Director Director of CSL Limited since August 2013 Ms McDonald has significant executive and non-executive experience in a number of sectors including law, medical research, manufacturing and chemicals. Through these roles, Ms McDonald brings experience and insight on financial markets, risk and compliance and change management. Ms McDonald is a former lawyer with over 30 years’ experience in the legal sector. She was previously a partner of Ashurst, specialising in mergers and acquisitions and corporate governance. She held the role of National Head of Mergers and Acquisitions and was Chair of the Corporations Committee of the Business Law Section of the Law Council of Australia and a member of the Australian Takeovers Panel for nine years. Other directorships and offices (current and recent): – Director of Nanosonics Limited (since October 2016); – Director of Nufarm Limited (since March 2017); and – Director of the Walter & Eliza Hall Institute of Medical Research (since October 2016). Board Committee memberships: – Member of the Audit and Risk Management Committee. – Member of the Human Resources and Remuneration Committee. Christine O’Reilly BBUS Age 59 Independent Non-executive Director Director of CSL Limited since February 2011 Ms O’Reilly has non-executive experience in a number of sectors including infrastructure, property, private health insurance, energy and medical research. She also has deep strategic and operational leadership experience, with a focus on corporate transformational change, debt and equity capital markets and merger and acquisitions. Ms O’Reilly was the co-head of Unlisted Infrastructure Investments at Colonial First State Global Asset Management from July 2007 until September 2012. Prior to this, she was the Chief Executive Officer of the GasNet Australia Group. Ms O’Reilly’s early work history includes participating in the reform and establishment of the regulatory framework for the Australian gas industry, eight years with the investment bank, Centaurus Corporate Advisory Services, and audit experience with Price Waterhouse where she qualified as a chartered accountant. Other directorships and offices (current and recent): – Director of Transurban Group (since April 2012); – Director of Medibank Private Limited (since March 2014); – Director of Stockland Limited (since August 2018); – Director of Baker Heart and Diabetes Institute (since July 2013); and – Former Director at Energy Australia Holdings Limited (from September 2012 to August 2018). Board Committee memberships: – Chairman of the Corporate Governance and Nomination Committee. – Member of the Audit and Risk Management Committee. – Member of the Human Resources and Remuneration Committee. Pascal Soriot DVM, MBA Age 61 Independent Non-executive Director Director of CSL Limited since August 2020 Mr Soriot has non-executive experience in the clincial-stage biotechnology sector. Mr Soriot brings a passion for science and medicine as well as significant experience in established and emerging markets, strength of strategic thinking, a successful track record of managing change and executing strategy, and the ability to lead a diverse organisation. Mr Soriot is the Chief Executive Officer of AstraZeneca, and has held this position since 2012. Before this he served as Chief Operating Officer of Roche’s pharmaceuticals division from 2010 to September 2012 and, prior to that, Chief Executive Officer of Genentech, a biologics business, where he led its successful merger with Roche. Mr Soriot joined the pharmaceutical industry in 1986 and has worked in senior management roles in numerous major companies around the world. Other directorships and offices (current and recent): – Chief Executive Officer of AstraZeneca (since October 2012); and – Former Director of Viela Bio, Inc (fromOctober 2019 to August 2020). Fiona Mead LLB (Hons), BComm Age 51 Company Secretary and Head of Corporate Governance Ms Mead was appointed Company Secretary and Head of Corporate Governance effective June 2018. Previously, she was the Company Secretary and a member of the Executive Leadership Team at Tabcorp Holdings Limited. Prior to that, Ms Mead was the Company Secretary at Asciano Limited, and earlier, Assistant Company Secretary at Telstra. Fiona began her career as a lawyer with law firm Ashurst. Ms Mead is a fellow of the Governance Institute of Australia and a graduate member of the Australian Institute of Company Directors. CSL Limited Annual Report 2020 57